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Has1 were regulated upon explantation but their expression appeared to
be independent of FGF2.
Conclusions: Murine cartilage injury mirrors that seen in porcine tissue
and reveals distinct cellular responses to explantation and re-cutting.
The re-cutting response is almost exclusively due to FGF2. Explantation
elicits activation of inﬂammatory signalling and leads to the induction
of genes; both FGF2-dependent, and FGF2-independent. The upstream
pathway through which non-FGF dependent signals are initiated upon
explantation is currently unknown.
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Purpose: Mitochondria is acquiring an important role in the osteoarthtritis
pathology (OA). IL-1beta is one of the main cytokines related to the in-
ﬂammation and the destruction of the cartilage which is known to regulate
mitochondrial functionality and to produce nitric oxide (NO). Previously,
we have described the total proteome of chondrocytes regulated by IL-
1beta identifying some mitochondrial proteins. Nevertheless, the exact role
that IL-1beta has in the regulation of mitochondrial protein expression and
their implication in the OA process, is not well understood. For this reason,
we analyzed the mitochondrial protein expression proﬁle by the action of
IL-1beta, in order to understand the development of different rheumatic
pathologies.
Methods: Human normal chondrocytes were isolated from the cartilage
of knees of autopsies from donors without previous history of joint dis-
ease. The cells were incubated for 48 hours in basal conditions or with
IL-1beta (5 ng/ml) and mitochondrial proteins were puriﬁed. A pool of
these mitochondrial proteins of 4 different donors in each condition, was
resolved by bidimensional electrophoresis (2-DE). Proteins were visualized
with Sypro stain. The qualitative and quantitative analysis were carried
out with PD-QUEST software. After that, proteins were identiﬁed by mass
spectrometry (MS) using the MALDI-TOF/TOF technology. The validation of
the results and the study of interesting proteins were made by real-time
PCR, western blot and microscopy. Total NO quantiﬁcation was evaluated
with Griess reagent assays.
Results: The comparative analysis of mitochondrial proteome of chon-
drocytes stimulated with IL-1beta for 48 hours with respect to the
basal situation revealed a differential expression of signal transduction
proteins, regulators of cytoskeleton, transcription, metabolic and stress
related pathways. IL-1beta increased with respect to the basal situation
different proteins like annexin A2 (ANXA2) or mitochondrial superoxide
dismutase (SOD2). Another protein that increased its expression 2.59 times
by IL-1beta with respect to basal condition was dimethylargininase 2
(DDAH2) (basal=1, n=4; *P<0.05). This protein has an important role as
regulator of NO synthesis when it hydrolyzes the inhibitor of NO synthase,
ADMA. DDAH2 did not show any regulation at mRNA nor total protein
expression after the stimulation with IL-1beta, nevertheless the study of
mitochondrial extracts showed a clear increase of DDAH2 in the condition
of IL-1beta with respect to the basal situation (4.18±1.41 vs. basal=1, n=4;
*P<0.05). By means of techniques of conventional inmunoﬂuorescence and
confocal microscopy, we observed that DDAH2 was located again in the
mitochondria of IL-1beta-stimulated chondrocytes. These results were also
reproducible in cartilage slices treated with IL-1beta. In addition to this
we demonstrated that DDAH2, which didn’t have been before described
in chondrocytes nor cartilage, regulated the NO production induced by
IL-1beta.
Conclusions: Our studies indicate that IL-1beta increased the expression of
certain proteins with a mitochondrial localization such as DDAH2 that was
identiﬁed for the ﬁrst time in human normal chondrocytes and cartilage.
It seemed to have an important role in the IL-1beta-NO production. Its
speciﬁc localization in the mitochondria could help to understand the role
of this organell and NO in rheumatic pathologies.
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Introduction: PAR-2 has been implicated in cartilage breakdown in arthritis
because: (i) it is expressed by chondrocytes and upregulated in osteoarthri-
tis (OA) and by IL-1 and TNF; (ii) its activation increases MMP expression
and activity in cartilage in vitro; and (iii) PAR-2 KO mice have reduced
inﬂammatory arthritis. PAR-2 is unique in being activated by APC but not
thrombin. APC is synthesized by chondrocytes and can activate cartilage
MMPs causing cartilage breakdown. In this study we investigated the
role and relationship of PAR-2 and APC in MMP activation and cartilage
degradation.
Methods: Femoral head cartilage from wild-type (WT; C57/BL6) and PAR-2
knock-out (KO) mice was cultured ± 10ng/mL IL-1±20μg/mL APC for 4
days in serum-free media. Glycosaminoglycan (GAG) and collagen (hydrox-
yproline) release, and MMP-2, -9 and -13 activity in conditioned media
were analysed. Chondrocyte expression of matrix proteins and enzymes
was measured by qRT-PCR.
The onset and progression of medial-meniscal-destabilization (DMM)-
induced OA in knees of WT and PAR-2 KO mice was quantiﬁed histo-
logically 4 and 8 weeks after surgery for: cartilage aggrecan loss (0-3),
erosion (0-7), and chondrocyte hypertrophy (0-1); osteophyte size (0-3)
and maturity (0-3); and subchondral bone sclerosis (0-3). All differences
reported below were statistically signiﬁcant p < 0.05.
Results: As previously described in other species, APC alone did not induce
GAG or collagen release from WT mouse cartilage. IL-1-induced GAG re-
lease was augmented by APC, and collagen release was induced in IL-1+APC
cultures. IL-1 increased pro-MMP-9 and active MMP-13 release from WT
mouse cartilage, while IL-1+APC increased active MMP-2, -9 and -13. IL-1
increased mRNA expression for endothelial protein C receptor, ADAMTS-4,
TIMP-1, MMP-9, and this was unaltered by APC. There was no difference in
GAG release, MMP activation or the response to IL-1 ± APC in PAR-2 KO
compared with WT cartilage. PAR-2 KO chondrocytes expressed increased
IL-1-induced ADAMTS-5 mRNA and lacked PAR-2 mRNA compared with
WT. There was a decrease in tibial cartilage aggrecan loss and structural
damage 4 but not 8 weeks after DMM in PAR-2KO mice. There was no
difference in osteophytes between genotypes, but PAR-2 KO mice had
reduced subchondral bone sclerosis at 4 and 8 weeks after DMM.
Discussion: APC activates mouse cartilage MMPs similar to our previous
studies in sheep, with subtle differences associated with articular versus
epiphyseal cartilage. Actual release of collagen from cartilage only occurs
with co-activation of MMP-2, -9 and -13. APC-induced activation of MMPs
and cartilage degradation does not require PAR-2. Furthermore, PAR-2 does
not appear to be critical for IL-1-induced cartilage degradation. The increase
in IL-1-induced ADAMTS-5 mRNA in PAR-2 KO chondrocytes suggests that
activation of PAR-2 normally acts as a negative regulator of this enzyme.
The early inhibition of DMM-induced cartilage damage in PAR-2 KO mice
could be associated with a reduction in the post-surgical inﬂammation.
The early and sustained inhibition in subchondral bone change in PAR-2
KO mice is consistent with the role of PAR-2 in osteoblast activity and
osteoclast differentiation/activation but suggests that cartilage and bone
change in this OA model are not co-dependent.
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Purpose: Osteoarthritis (OA) is a common age-related joint disease. As in
other age-related degenerative diseases, such as those of the cardiovascular
system, altered lipid metabolism has been implicated as a critical player in
disease development. Increased serum cholesterol has been considered a
risk factor for OA independent of obesity and also articular manifestations
have been demonstrated in familial hypercholesterolemia patients.
As excessive accumulation of free cholesterol is toxic for the cells, intra-
cellular cholesterol accumulation is prevented by tight regulation of inﬂux
and eﬄux pathways. We have previously shown that chondrocytes are
